Advertisement
Screener

Aurinia Pharmaceuticals Inc. (AUPH) Outstanding Bonds: Outstanding

Aurinia Pharmaceuticals Inc. Outstanding Bonds

Note series still outstanding, nearest maturity first. Terms are from each offering's final pricing term sheet on SEC EDGAR; a reopening of the same CUSIP adds to its principal. Interest per payment = principal × coupon ÷ payments per year. Outstanding = principal issued minus each filed exchange, tender, redemption or conversion; it is (m) where the retired amount was not filed. Interest per payment uses the outstanding principal.

NotesPrincipal issuedOutstandingCouponTrade dateIssue / settlement dateMaturity dateInterest payment datesInterest per paymentAnnual coupon interestOptional redemptionRetiredPriced

Similar stocks

Stock NameCountryMarket CapPE Ratio
Zai Lab Ltd (ZLAB)$2.241B-113.34
Prestige Consumer Healthcare Inc. (PBH)United States$2.163B13.03
OCULAR THERAPEUTIX, INC (OCUL)United States$2.159B-7.15
Bausch Health Companies Inc. (BHC)$2.113B-1.68
Braveheart Bio, Inc. (BRVE)United States$2.106B
PALVELLA THERAPEUTICS, INC. (PVLA)United States$2.105B-35.55
Trevi Therapeutics, Inc. (TRVI)United States$2.091B-51.93
Viridian Therapeutics, Inc.\DE (VRDN)United States$2.342B-5.38
Mineralys Therapeutics, Inc. (MLYS)United States$2.353B-6.82
Generate Biomedicines, Inc. (GENB)United States$2.052B